iRhythm EPS IRTC
Diluted earnings per share by quarter and over the last twelve months, from 2015.
- Last 12 months, to Jun 30, 2026
- −$0.43
- Latest quarter, Q2 FY26
- −$0.01
- Fiscal year 2025
- −$1.40
iRhythm's earnings per share was −$0.43 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.01.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.40 | n/a |
| FY2024 | −$3.64 | n/a |
| FY2023 | −$4.05 | n/a |
| FY2022 | −$3.89 | n/a |
| FY2021 | −$3.45 | n/a |
| FY2020 | −$1.59 | n/a |
| FY2019 | −$2.14 | n/a |
| FY2018 | −$2.10 | n/a |
| FY2017 | −$1.30 | n/a |
| FY2016 | −$10.60 | n/a |
| FY2015 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.01 | n/a | −$0.43 | |
| Q1 FY26 | −$0.43 | n/a | −$0.86 | |
| Q4 FY25 | $0.17 | n/a | −$1.40 | |
| Q3 FY25 | −$0.16 | n/a | −$1.61 | |
| Q2 FY25 | −$0.44 | n/a | −$2.93 | |
| Q1 FY25 | −$0.97 | n/a | −$3.14 | |
| Q4 FY24 | −$0.04 | n/a | −$3.64 | |
| Q3 FY24 | −$1.48 | n/a | −$4.86 | |
| Q2 FY24 | −$0.65 | n/a | −$4.27 | |
| Q1 FY24 | −$1.47 | n/a | −$4.23 | |
| Q4 FY23 | −$1.26 | n/a | −$4.05 | |
| Q3 FY23 | −$0.89 | n/a | −$3.46 |
Against its peers
Companies in Medical - Instruments & Supplies nearest iRhythm's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| IRTCiRhythm | −$0.43 | |
| ICUIICU Medical | $1.18 | |
| NVSTEnvista | $0.58 | +81% a year |
| BMIBadger Meter | $4.28 | −8% a year |
| VNTVontier | $2.41 | −8% a year |
| WRBYWarby Parker | $0.07 | |
| ATRCAtriCure | $0.21 | |
| HAEHaemonetics | $2.04 | −38% a year |
| MMSIMerit Medical Systems | $2.42 | +23% a year |
| UFPTUFP Technologies | $9.28 | +8% a year |
| MSAMSA Safety | $8.04 | +15% a year |
| Peer median | $2.23 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on iRhythm
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.